Leon Cooperman's AVBP Position Overview
Leon Cooperman (via Cooperman Leon G) currently holds 0 shares of ArriVent BioPharma, Inc. (AVBP) worth $0, representing 0.00% of the portfolio. First purchased in 2025-Q2, this short-term holding has been held for 3 quarters.
Based on 13F filings, Leon Cooperman has maintained this position in AVBP for several quarters, showing initial confidence in the investment. Largest reduction occurred in Q4 2025, reducing 421,278 shares.
Analysis based on 13F filings available since 2013 Q2
Leon Cooperman's ArriVent BioPharma (AVBP) Holding Value Over Time
Track share changes against reported price movement
Quarterly ArriVent BioPharma (AVBP) Trades by Leon Cooperman
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -421,278 | Sold Out | 0 | $0.00 |
| Q2 2025 | +421,278 | New Buy | 421,278 | $21.77 |
Leon Cooperman's ArriVent BioPharma Investment FAQs
Leon Cooperman first purchased ArriVent BioPharma, Inc. (AVBP) in Q2 2025, acquiring 421,278 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Leon Cooperman has held ArriVent BioPharma, Inc. (AVBP) for 3 quarters since Q2 2025.
Leon Cooperman's largest addition to ArriVent BioPharma, Inc. (AVBP) was in Q2 2025, adding 421,278 shares worth $9.17 M.
According to the latest 13F filing for Q4 2025, Leon Cooperman's firm, Cooperman Leon G, owns 0 shares of ArriVent BioPharma, Inc. (AVBP), valued at approximately $0.
As of the Q4 2025 filing, ArriVent BioPharma, Inc. (AVBP) represents approximately 0.00% of Leon Cooperman's publicly disclosed stock portfolio, making it one of their key holdings.
Leon Cooperman's peak holding in ArriVent BioPharma, Inc. (AVBP) was 421,278 shares, as reported at the end of Q2 2025.